Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk

Carcinogenesis

Volumn 27, Issue 12, 2006, Pages 2519-2527

  Kaufmann, William K ^a   Filatov, Leonid ^a   Oglesbee, Stephen E ^a   Simpson, Dennis A ^a   Lotano, Marc A ^a   McKeen, Hayley D ^a   Sawyer, Lynda R ^a   Moore, Dominic T ^a   Millikan, Robert C ^a   Cordeiro Stone, Marila ^a   Carey, Lisa A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BIOLOGICAL MARKER; CELL DNA;

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RISK; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHROMATID ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA CONTENT; DNA DAMAGE; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; FEMALE; GENETIC SUSCEPTIBILITY; GENOTOXICITY; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IONIZING RADIATION; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIOSENSITIVITY; VIRUS CELL TRANSFORMATION;

BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CONTINENTAL POPULATION GROUPS; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENES, P53; HUMANS; MIDDLE AGED; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEINS;

EID: 33750320204     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl103     Document Type: Article

References (53)

1. Olivier,M., Eeles,R., Hollstein,M., Khan,M.A., Harris,C.C. and Hainaut,P. (2002) The IARC TP53 database: New online mutation analysis and recommendations to users. Hum. Mutat., 19, 607-614.
2. Frebourg,T., Barbier,N., Yan,Y.X., Garber,J.E., Dreyfus,M., Fraumeni,J.,Jr, Li,F.P. and Friend,S.H. (1995) Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am. J. Hum. Genet., 56, 608-615.
3. Malkin,D., Li,F.P., Strong,L.C. et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
4. Bell,D.W., Varley,J.M., Szydlo,T.E. et al. (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [see comments]. Science, 286, 2528-2531.
5. Li,F.P. (1996) Hereditary cancer susceptibility. Cancer, 78, 553-557.
6. Vahteristo,P., Bartkova,J., Eerola,H. et al. (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am. J. Hum. Genet., 71, 432-438.
7. Lane,D.P. (1992) Cancer. p53, guardian of the genome [news; comment] [see comments]. Nature, 358, 15-16.
8. Hartwell,L.H. and Kastan,M.B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
9. Amundson,S.A., Patterson,A., Do,K.T. and Fornace,A.J.,Jr (2002) A nucleotide excision repair master-switch: P53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther., 1, 145-149.
10. Zhou,J., Ahn,J., Wilson,S.H. and Prives,C. (2001) A role for p53 in base excision repair. EMBO J., 20, 914-923.
11. Yang,Q., Zhang,R., Wang,X.W. et al. (2002) The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J. Biol. Chem., 277, 31980-31987.
12. Chehab,N.H., Malikzay,A., Appel,M. and Halazonetis,T.D. (2000) Chk2/ hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev., 14, 278-288.
13. Hirao,A., Kong,Y.Y., Matsuoka,S., Wakeham,A., Ruland,J., Yoshida,H., Liu,D., Elledge,S.J. and Mak,T.W. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science, 287, 1824-1827.
14. Miki,Y., Swensen,J., Shattuck-Eidens,D. et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
15. Wooster,R., Bignell,G., Lancaster,J., Swift,S., Seal,S., Mangion,J., Collins,N., Gregory,S., Gumbs,C. and Micklem,G. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.
16. Wang,Y., Cortez,D., Yazdi,P., Neff,N., Elledge,S.J. and Qin,J. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev., 14, 927-939.
17. Xu,B., Kim,S. and Kastan,M.B. (2001) Involvement of brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol., 21, 3445-3450.
18. Xu,B., Kim,S.T., Lim,D.S. and Kastan,M.B. (2002) Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol., 22, 1049-1059.
19. Patel,K.J., Vu,V.P., Lee,H., Corcoran,A., Thistlethwaite,F.C., Evans,M.J., Colledge,W.H., Friedman,L.S., Ponder,B.A. and Venkitaraman,A.R. (1998) Involvement of Brca2 in DNA repair. Mol. Cell, 1, 347-357.
20. Howlett,N.G., Taniguchi,T., Olson,S. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609.
21. Athma,P., Rappaport,R. and Swift,M. (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet., 92, 130-134.
22. Boultwood,J. (2001) Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J. Clin. Pathol., 54, 512-516.
23. Bakkenist,C.J. and Kastan,M.B. (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 421, 499-506.
24. 2-phase lymphocytes as an indicator of cancer predisposition. Radiat. Res., 145, 3-16.
25. Taylor,A.M., Harnden,D.G., Arlett,C.F., Harcourt,S.A., Lehmann,A.R., Stevens,S. and Bridges,B.A. (1975) Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature, 258, 427-429.
26. Zampetti-Bosseler,F. and Scott,D. (1981) Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 39, 547-558.
27. 2 phase X irradiation, a marker of the ataxia-telangiectasia gene. J. Natl Cancer Inst, 82, 1050-1054.
28. 2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genet. Cytogenet., 14, 163-168.
29. 2 phase chromosomal radiosensitivity of peripheral blood lymphocytes. Hum. Genet., 101, 312-316.
30. Bebb,D.G., Steele,P.P., Warrington,P.J., Moffat,J.A. and Glickman,B.W. (1998) Caffeine does not potentiate gamma-radiation induced DNA damage in ataxia telangiectasia lymphoblastoid cells. Mutat. Res., 401, 27-32.
31. Wiencke,J.K., Wara,D.W., Little,J.B. and Kelsey,K.T. (1992) Heterogeneity in the clastogenic response to X-rays in lymphocytes from ataxia-telangiectasia heterozygotes and controls. Cancer Causes Control, 3, 237-245.
32. Roberts,S.A., Spreadborough,A.R., Bulman,B., Barber,J.B., Evans,D.G. and Scott,D. (1999) Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer? Am. J. Hum. Genet., 65, 784-794.
33. Scott,D., Spreadborough,A., Levine,E. and Roberts,S.A. (1994) Genetic predisposition in breast cancer. Lancet, 344, 1444.
34. Patel,R.K., Trivedi,A.H., Arora,D.C., Bhatavdekar,J.M. and Patel,D.D. (1997) DNA repair proficiency in breast cancer patients and their firstdegree relatives. Int. J. Cancer, 73, 20-24.
35. Parshad,R., Price,F.M., Bohr,V.A., Cowans,K.H., Zujewski,J.A. and Sanford,K.K. (1996) Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer, 74, 1-5.
36. 2 chromosomal radiosensitivity in fibroblasts of ataxia-telangiectasia heterozygotes and a Li-Fraumeni syndrome patient with radioresistant cells. Int. J. Radiat. Biol., 72, 435-438.
37. Buchholz,T.A., Wu,X., Hussain,A., Tucker,S.L., Mills,G.B., Haffty,B., Bergh,S., Story,M., Geara,F.B. and Brock,W.A. (2002) Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int. J. Cancer, 97, 557-561.
38. Wei,Q., Spitz,M.R., Gu,J., Cheng,L., Xu,X., Strom,S.S., Kripke,M.L. and Hsu,T.C. (1996) DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol. Biomarkers Prev., 5, 199-204.
39. Yu,G.P., Zhang,Z.F., Hsu,T.C., Spitz,M.R. and Schantz,S.P. (1999) Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett., 146, 93-101.
40. Spitz,M.R., Wu,X., Jiang,H. and Hsu,T.C. (1996) Mutagen sensitivity as a marker of cancer susceptibility. J. Cell Biochem. Suppl., 25, 80-84.
41. 2 phase delay in ataxia telangiectasia heterozygotes. Cancer Genet. Cytogenet., 60, 183-187.
42. Beamish,H., Khanna,K.K. and Lavin,M.F. (1994) Ionizing radiation and cell cycle progression in ataxia telangiectasia. Radiat Res., 138 (Suppl. 1), S130-S133.
43. Lavin,M.F., Bennett,I., Ramsay,J., Gardiner,R.A., Seymour,G.J., Farrell,A. and Walsh,M. (1994) Identification of a potentially radiosensitive subgroup among patients with breast cancer [see comments]. J. Natl Cancer Inst., 86, 1627-1634.
44. Hu,J.J., Smith,T.R., Miller,M.S., Lohman,K. and Case,L.D. (2002) Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ. Mol. Mutagen., 39, 208-215.
45. 2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene, 16, 1825-1838.
46. Hsu,T.C., Wu,X. and Trizna,Z. (1996) Mutagen sensitivity in humans. A comparison between two nomenclature systems for recording chromatid breaks. Cancer Genet. Cytogenet., 87, 127-132.
47. Robertson,T., Wright,F.T. and Dykstra,R.L. (1988) Order Restricted Statistical Inference. New York: Wiley and Sons.
48. Bender,M.A., Rary,J.M. and Kale,R.P. (1985) G2 chromosomal radiosensitivity in ataxia telangiectasia lymphocytes. Mutat Res, 152, 39-47.
49. Deming,P.B., Cistulli,C.A., Zhao,H., Graves,P.R., Piwnica-Worms,H., Paules,R.S., Downes,C.S. and Kaufmann,W.K. (2001) The human decatenation checkpoint. Proc. Natl Acad. Sci. USA, 98, 12044-12049.
50. Shiloh,Y. (2003) ATM and related protein kinases: Safeguarding genome integrity. Nat. Rev. Cancer, 3, 155-168.
51. Swift,M. (2001) Public health burden of cancer in ataxia-telangiectasia heterozygotes. J. Natl Cancer Inst., 93, 84-85.
52. Berwick,M. and Vineis,P. (2000) Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review. J. Natl Cancer Inst., 92, 874-897.
53. Hu,J.J., Smith,T.R., Miller,M.S., Mohrenweiser,H.W., Golden,A. and Case,L.D. (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis, 22, 917-922.